Stock Events

Stock Events

Wuxi Biologics (Cayman) 

$5.58
71
-$0.32-5.42%Friday 15:57

Statistics

Day High
6.45
Day Low
6.45
52W High
7.49
52W Low
3.9
Volume
4,000
Avg. Volume
4,721
Mkt Cap
23.12B
P/E Ratio
27.06
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Aug 25Expected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0.24
0.39
0.55
0.71
Expected EPS
0.51912652572
Actual EPS
0.669096410928

Financials

22.52%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
3.08BRevenue
693.76MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow WXIBF. It's not an investment recommendation.
Apple
13
AAPL
Microsoft
12
MSFT
NVIDIA
12
NVDA
Tesla
10
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sartorius
SARTF
Mkt Cap14.69B
Sartorius Stedim Biotech is a supplier of equipment and services for biopharmaceutical manufacturing, competing in the bioprocessing space with Wuxi Biologics.
Charles River Laboratories International
CRL
Mkt Cap13.85B
Charles River Laboratories offers a broad range of services to support the pharmaceutical and biotech industries, including biologics testing services.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific provides bioproduction and bioprocessing products and services, competing with Wuxi Biologics in the supply of critical biomanufacturing technologies.
Danaher
DHR
Mkt Cap150.48B
Danaher, through its subsidiaries like Cytiva, competes in the bioprocessing space by providing technologies and services for biomanufacturing.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories offers products and services in the field of life science research and clinical diagnostics, competing in the biologics tools and services market.
IQVIA
IQV
Mkt Cap42.5B
IQVIA provides advanced analytics, technology solutions, and contract research services to the life sciences industry, competing in the broader biopharmaceutical services market.
Pfizer
PFE
Mkt Cap158.45B
Pfizer, through its contract manufacturing organization Pfizer CentreOne, competes in the biologics manufacturing and development services sector.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences, while primarily a biopharmaceutical company, competes for resources, talent, and market share in the biologics sector, particularly in areas of overlapping therapeutic interest.

About

WuXi Biologics (Cayman) Inc. provides extensive global services, spanning the entire biopharmaceutical process from drug discovery to advanced development and manufacturing, catering to clients in China, North America, Europe, and other international markets. The company also offers expert consultation in biopharmaceutical technology, facilitates international sales contracting, develops and performs advanced testing services, and manages sales and marketing initiatives. Furthermore, it provides clinical and manufacturing support for biologics, manufactures and distributes medical products, serves as a contract development and manufacturing organization (CDMO) for vaccines, and functions as a material supplier. WuXi Biologics maintains significant strategic collaborations with partners such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc. The organization, founded in 2014, is headquartered in Wuxi, China.
Show More
CEO
Zhisheng Chen
Employees
13252
Country
Cayman Islands
ISIN
KYG970081173
WKN
000A2QJCN

Listings

MU
DE
1FW.MU
STU
DE
1FW1.STU
STU
DE
1FW2.STU
MU
DE
1FW1.MU

0 Comments

Share your thoughts

FAQs

What is Wuxi Biologics (Cayman) stock price today?▼
The current price of WXIBF is $5.58 USD — it has decreased by -5.42% in the past 24 hours. Watch Wuxi Biologics (Cayman) stock price performance more closely on the chart.
What is Wuxi Biologics (Cayman) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Wuxi Biologics (Cayman) stocks are traded under the ticker WXIBF.
Is Wuxi Biologics (Cayman) stock price growing?▼
WXIBF stock has fallen by -13.49% compared to the previous week, the month change is a -17.58% fall, over the last year Wuxi Biologics (Cayman) has showed a +21.3% increase.
What is Wuxi Biologics (Cayman) market cap?▼
Today Wuxi Biologics (Cayman) has the market capitalization of 23.12B
When is the next Wuxi Biologics (Cayman) earnings date?▼
Wuxi Biologics (Cayman) is going to release the next earnings report on March 23, 2027.
What were Wuxi Biologics (Cayman) earnings last quarter?▼
WXIBF earnings for the last quarter are 0.09 USD per share, whereas the estimation was 0.07 USD resulting in a +28.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Wuxi Biologics (Cayman) revenue for the last year?▼
Wuxi Biologics (Cayman) revenue for the last year amounts to 3.08B USD.
What is Wuxi Biologics (Cayman) net income for the last year?▼
WXIBF net income for the last year is 693.76M USD.
How many employees does Wuxi Biologics (Cayman) have?▼
As of November 1, 2026, the company has 13,252 employees.
In which sector is Wuxi Biologics (Cayman) located?▼
Wuxi Biologics (Cayman) operates in the Health & Wellness sector.
When did Wuxi Biologics (Cayman) complete a stock split?▼
The last stock split for Wuxi Biologics (Cayman) was on December 10, 2020 with a ratio of 3:1.
Where is Wuxi Biologics (Cayman) headquartered?▼
Wuxi Biologics (Cayman) is headquartered in Wuxi, Cayman Islands.